Fundraising Fox
Qiming Venture Partners
Venture capitalActively deployingBeijing · Seed–Series B · 64 people tracked
Also known as QIMING CAYMAN, LTD · QIMING GLOBAL MANAGEMENT, LLC
Find your way into Qiming Venture Partners
Sign up to see every warm intro you have to Qiming Venture Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Qiming Venture Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Qiming Venture Partners seeks out future-defining companies capable of creating long-term value for society. The firm emphasizes deep trust between its investors, limited partners, and founders, offering entrepreneurs full access to its industry network and its proprietary ecosystem of value-added services. It helps founders build strong teams, connect with third-party advisors, and navigate critical milestone events including fundraising, IPOs, and mergers and acquisitions, supporting them through periods of strategic decision-making and competitive pressure. Its portfolio spans technology sectors such as AI, robotics, autonomous driving, internet platforms, and enterprise software, as well as extensive investments in healthcare, biotech, and innovative pharmaceuticals across China.
Source: firm website, verified Oct 13, 2026.
Team · 64 people
from the firm's website & curated & public directories
Gary Rieschel, an American venture capitalist who moved full‑time to Shanghai, maintained long-term U.S.–China commitment, backed early-stage Xiaomi, and is frequently invited to policy forums to explain China's innovation system.
JP Gan is a long‑tenured investor in Chinese consumer internet who backed Bilibili and Musical.ly/TikTok, keeps decades-long board roles, and blends fundamental analysis, product vision and global capital bridging.
Zhifeng Zhou is an executive officer associated with Qiming Global Management LLC, the management entity behind Qiming Venture Partners. Public SEC Form D filings name him as an executive officer across several Qiming Venture Partners IX funds raised in the 2011-2026 period. His firm is registered at an address in The Landmark, Central. Beyond these capital-raising filings, the available pages provide limited additional detail about his career or investment focus.
Duane Kuang is a founding managing partner who built his firm as a 100‑year institution, weathering China’s macro cycles by staying fully invested and deliberately building deep, succession-ready leadership.
Co-founder of Qiming US (2017) with over 30 years of operating experience in healthcare and life science companies. Previously EVP and COO at UCB, CEO of PDL Biopharma and Signature Bioscience, and a founder of Corixa Corporation.
Alex Zhou is a managing partner at Qiming Venture Partners focused on AI, robotics and frontier technology. He led Qiming's pre-ChatGPT investment in Zhipu AI and was a founding investor in GPU maker Biren Technology; his portfolio spans UBTech Robotics, Roborock and StepFun. Earlier he worked at Kleiner Perkins and ran Hewlett-Packard's China data-storage unit.
Bonnie Wang, based in Shanghai, focuses on new‑generation Chinese consumer and internet companies (e.g., PETKIT, NEIWAI), using her Egon Zehnder executive‑search experience for talent assessment and active board guidance.
Janet Yu, Partner and Head of RMB Funds, leads onshore renminbi vehicles and strategy, specializing in RMB fundraising, government relations and LP relationships with Chinese institutional and government-linked capital.
Kuantai Yeh is a TMT-focused partner who uses a three-sign framework—CIO budgets, vendor maturity, customer adoption—to time China enterprise software deals, emphasizing deep tech moats, system-level innovation, semiconductors and VR.
Nisa Leung founded and led Qiming Venture Partners' healthcare practice from 2006 until stepping down as managing partner in early 2025, building one of the most prolific healthcare portfolios in Asian venture capital.
Shiyu Wang rejoined as Partner and co-lead of the TMT team after a stint at K2VC and is a public-facing expert on Chinese consumer and beauty brands' international strategies.
Kan Chen is a scientist-turned-investor who leads biotech investments as a Partner and co-lead of healthcare at Qiming Venture Partners. Before joining Qiming in 2016, he spent about 12 years in academic and industry roles, including at the Cleveland Clinic, Harvard Medical School, Johnson & Johnson, and Jiangsu Hengrui Medicine, with expertise across cardiovascular disease, immunology, and cancer. During his academic career he published six papers cited around 900 times, and in industry he contributed to the development of the cancer therapy Camrelizumab, later approved by China's NMPA. At Qiming he has sourced over 30 deals and serves on the boards of more than 20 portfolio companies. His portfolio includes Insilico Medicine, LaNova Medicines, MediLink Therapeutics, Structure Therapeutics, and Abbisko. He earned a PhD in cell biology through a joint Cleveland Clinic and Case Western Reserve University program, completed postdoctoral training in immunology, and holds a bachelor's degree from Fudan University.
William Hu built his firm's medical innovation strategy and co-leads healthcare investing, growing a China-focused portfolio across biopharma, devices, diagnostics and services while championing a Big Healthcare ecosystem mindset.
Cindy Liu, a Shanghai-based Principal, specializes in targeted biotech investments and leverages a healthcare and frontier-tech background—from TransportationTech to Web3 and AI—to support founders at biotech, data, and AI intersections.
Jinda Gao is a healthcare-focused principal who leads AI-enabled medical services and digital health investments—championing impact-driven senior care and clinical decision support platforms that align returns with societal needs.
Jing Liu, a PhD-trained cell and developmental biologist and former Novartis Research Fellow, brings experimental biology and pharma R&D experience plus a crossover US–China healthcare investment perspective for therapeutic development.
Qi Hu, a Principal specializing in AI and infrastructure software, combines hands-on AI engineering and management experience, early backing of Zhipu AI, Shengshu Tech and Stepfun, and multidisciplinary degrees.
Dr. Alexander Sinclair-Wilson is a Europe-based Principal who leverages his doctoral scientific expertise to evaluate and back therapeutics-focused, science-driven founders, acting as a bridge to China/US networks for UK/European biotech.
Shuo Mao, Principal/VP, has focused on healthcare since 2015—specializing in advanced medtech and neuro technologies including brain-computer interfaces—and offers a China–U.S. cross‑border perspective from Rochester education and Beijing base.
Nan Chen focuses on hard-tech—especially advanced manufacturing, semiconductors, network infrastructure, magnetic levitation, hydrogen and fusion—and judges if tough engineering becomes scalable products; Qiming and industry awards recognize his manufacturing expertise.
Helen Wong, a 20-year venture investor across Silicon Valley, China and Southeast Asia, translates China tech playbooks to Indonesia, specializes in solar investing (IRR/payback) and backed Xurya; named by Forbes.
Motao Sun is a Vice President at Qiming Venture Partners, where he focuses on early-stage healthcare investments. He has background experience across healthcare management, services, digital health, pharmaceuticals, and medical devices.
Oscar Zhang focuses on medical devices, health tech and surgical robotics, with 7+ years' healthcare investing, is board director at Broncus and was named a Top 15 Healthcare Glory Star.
Partner at Qiming US focused on early-stage biotech and health tech investing. Previously an analyst at Biomatics Capital and a consultant at LEK Consulting's life sciences team.
What they invest in
from 199 of 527 portfolio companiesHealthtech ×79Biotech ×74AI & Machine Learning ×57Medical Devices ×47Hardware ×36Deep Tech ×32Digital Health ×32Consumer ×25
HQs:China×115United States×42Hong Kong×2Indonesia×2Singapore×2United Arab Emirates×1
Who they back
founder profiles across 73 portfolio companiesFounding team size:solo founder×392 founders×233 founders×64+ founders×5
Where their founders studiedfrom 29 founders with education data
Massachusetts Institute of Technology ×3Baylor College of Medicine ×2Fudan University ×2Peking University ×2Tsinghua University ×2UC San Diego ×2University of Science and Technology of China ×2Zhejiang University ×2
What their founders studiedfrom 34 founders with field-of-study data
Engineering ×13Life Sciences ×9Computer Science ×6Business & Management ×5Physics ×5Mathematics & Statistics ×2
Where their founders worked beforefrom 28 founders with career history
IBM ×2
18 founders hold a PhD · 5 hold an MBA (of 34 with degree data)
Investments · 527 tracked
founders shown can be your intro pathBy year:2026 · 52025 · 72024 · 102023 · 82022 · 102021 · 62019 · 42018 · 32017 · 22016 · 12015 · 32013 · 263 dated
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.
BiotechHealthtechCambridge, US
Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in
Co-investorsAtlas VentureMC Healthcare VenturesNew Enterprise Associates (NEA)AlexandriaQiming Venture Partners USARock Springs Capital+3 more
Schrödinger develops a physics-based computational platform for discovering and optimizing molecules, used to accelerate drug discovery and materials design.
AI & Machine LearningBiotechDeep TechNew MaterialsNew York, US
Richard A. Friesner(Founder)Ramy Farid(Executive Officer, Director)inRamy Farid, Ph.D.(President and CEO, Board Member)Murco Ringnalda(Executive Officer)William Andrew Goddard III(Founder)William Goddard(Founder)
Co-investorsBill & Melinda Gates Foundation TrustGV (Google Ventures)Sixty Degree Capital
Tuya's LLM solution provides integrated AI services and customizable AI Copilot development tools that let businesses build, deploy, and evaluate large language models across sectors including real estate, healthcare, retail, and manufacturing.
AI & Machine LearningCloud ComputingEnterprise SoftwareHardwareIoT
Wang Xueji(Founder)
Co-investorsATM CapitalNew Enterprise Associates (NEA)Vision Plus CapitalHongShan Capital Group
Co-investorsChainfir CapitalINCE CapitalPreAngel Partners
WeRide develops autonomous driving technology and operates a portfolio of five core products, including Robotaxi, with vehicles deployed across more than 40 cities in 12 countries.
AI & Machine LearningMobility & TransportationRobotics
Yan(Co-founder)Tony Han(Founder)in
Co-investorsAlliance VenturesFoothill VenturesK3 VenturesK3V VenturesNautilus Ventures Management Company (Us), LlcSky9 Capital+1 more
Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.
BiotechHealthtechMedical Devices
Samantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYajing Chen(Chief Financial Officer)inRafael G. Amado(President, Head of Global Research and Development)inF. Ty Edmondson(Chief Legal Officer)inJosh Smiley(President and Chief Operating Officer)Samantha Du(Founder)
Co-investorsVivo CapitalYuanBio Venture CapitalAdvantech CapitalHongShan Capital GroupKleiner PerkinsSequoia Capital
Zhou Yuan(Founder)
Co-investorsAccess Technology VenturesBlue Lake CapitalPreAngel PartnersXVC Venture CapitalHongShan Capital GroupInnovation Works
CIX Tech designs semiconductor chips and processor solutions, with focus on ARM-based computing platforms for desktop and cloud applications.
AI & Machine LearningDeep TechHardwareSemiconductorsShanghai, CN
Co-investorsBAI capitalCornerstone CapitalNIO CapitalShunwei Capital
Dingke develops a range of vascular intervention devices, including balloon catheters for coronary, peripheral, and neurointervention procedures.
HardwareHealthtechMedical DevicesSuzhou, CN
Weng Yulin
Co-investorsChina Merchants Capital
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Greg Lazar, Ph.D.(Co-Founder and Chief Scientific Officer)Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)in
BoardAlicia Levey(Director)
Co-investorsSV Health InvestorsVersant VenturesAlexandriaDementia Discovery FundQiming HealthcareQiming Venture Partners USA
Empirico is a clinical-stage biotechnology company that pairs human genetics-driven target discovery with siRNA medicine development to create genetic medicines for common diseases with unmet need.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
Omri Gottesman(Co-Founder; Chief Executive Officer and President)Shannon Bruse(Co-Founder; SVP, Head of Target Discovery and Biology)Brian Cajes(Co-Founder; SVP, Head of Data Platforms and Engineering)Bill McLeod(Chief Financial Officer)Michael Molyneaux(Chief Medical Officer)David Lewis(SVP, Head of Drug Discovery and Development)
Co-investorsNeotribe VenturesDCVC Bio
Fxiaoke is a CRM platform and cloud service provider that builds Agentic CRM systems for mid-to-large enterprises in China.
AI & Machine LearningEnterprise SoftwareSaaSSales TechBeijing, CN
罗旭(Founder and CEO)Luo Xu(Founder)
Co-investorsDCMHillhouse CapitalIDG CapitalDCM Ventures
Guokang is a Chinese health management company providing private-doctor and corporate health management services, primarily to executives and directors of large enterprises, along with health insurance brokerage and an online health-management SaaS platform.
Digital HealthHealthtechSaaSWellness & FitnessShenzhen, CN
杨华山(Chairman & CEO)Yang Huashan(Chairman & CEO)
Co-investorsLYFE Capital
Immutrin is a biotechnology company developing antibody therapies designed to remove systemic amyloid deposits and reverse amyloidosis.
BiotechMedical Devices
Mark Pepys(Co-founder; Emeritus Professor of Medicine at UCL)Gregory Winter(Co-founder; Nobel Laureate)Daniel Christ(Co-founder; Professor, Faculty of Medicine, UNSW)
Co-investorsCambridge Innovation CapitalFrazier Life SciencesF-Prime CapitalSR One Capital Management
Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development.
AI & Machine LearningBiotechDigital HealthHealthtechHong Kong, US
Aleksandrs Zavoronkovs(Executive Officer, Director)Alex Zavoronkov(Director)Alex Zhavoronkov(Founder)inAlex Aliper(President)inFeng Ren(Chief Scientific Officer, Executive Director & Co-CEO)in
BoardNisa Leung(Director)in
Co-investorsLilly Asia VenturesOrbiMedWarburg PincusBaidu VenturesEight Roads VenturesLake Bleu Capital+13 more
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Bluebird VenturesByers CapitalCasdin Capital+7 more
M20 Genomics develops single-cell and spatial transcriptome sequencing technologies for life science research, drug discovery, and disease diagnosis applications.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesGaithersburg, US
Co-investorsSequoia Capital
Mech-Mind develops AI-based machine vision hardware and software—including 3D cameras, vision software, and robot programming tools—for industrial robotics applications.
Advanced ManufacturingAI & Machine LearningHardwareRoboticsBeijing, CN
Tianlan Shao(Founder)in
Co-investorsSource Code CapitalIDG CapitalIntel CapitalHongShan Capital Group
Micropoint Bio is a microfluidics technology company that develops point-of-care testing (POCT) devices and biochips for clinical diagnostics, including coagulation, cardiac, and infectious disease testing.
BiotechDeep TechHealthtechMedical DevicesShenzhen, CN
Co-investorsNorthern Light Venture CapitalSequoia CapitalShenzhen Capital Group
Oricell Therapeutics (原启生物) is a clinical-stage biopharmaceutical company developing cell therapies, including CAR-T products targeting GPRC5D for relapsed/refractory multiple myeloma and GPC3 for advanced liver cancer.
BiotechDeep TechHealthtechShanghai, CN
Helen Yang(Founder)inIris Huangin
Co-investorsVivo CapitalQuan CapitalRTW Investments L.P.
PRCXI manufactures laboratory equipment including oscillating incubators, shakers, and magnetic stirrers for scientific and research applications.
Advanced ManufacturingAgTechAI & Machine LearningBiotechHardwareHealthtechSuzhou, CN
Singular Medical develops implantable cardiac devices and digital health solutions for arrhythmia and heart failure management, including pacemakers, defibrillators, and remote monitoring systems.
Advanced ManufacturingBiotechDigital HealthHealthtechMedical DevicesSuzhou, CN
Co-investorsNorthern Light Venture CapitalMarathon Venture Partners
Shanghai Zhenge Biotech is an independent CDMO company providing contract development and manufacturing services for biopharmaceutical clients during clinical development and commercialization phases.
BiotechDeep TechHealthtechShanghai, CN
Chen Jianxin(Chief Executive Officer)
Co-investorsCMB InternationalIDG Capital
Xiaoman is an AI-powered foreign trade service platform that helps Chinese export merchants find new customers, identify business opportunities, and manage operations using artificial intelligence technology.
AI & Machine LearningE-commerceEnterprise SoftwareMarketing TechSaaSSales TechBeijing, CN
Co-investorsZero-One CapitalZhenFund01vcChina Growth Capital
Austin, US
Brian Magierski(Executive Officer, Director, Promoter)Steve Papermaster(Executive Officer, Director, Promoter)
Board seatGary Rieschel· per SEC Form D
Co-investorsTrue VenturesWestern Technology Investment
Madaket operates a SOC 2 Type 2-compliant platform that ingests, standardizes, validates, and synchronizes provider data for the healthcare provider–payer ecosystem.
Data & InfrastructureDigital HealthHealthtechSaaSCambridge, US
James P. Dougherty(Executive Officer, Director)Ted Achtem(Chief Data Officer)inMegan Schmidt(CEO)inJerry Held(Director)Archibald Cox(Director)Jeannine Dahling(Chief Operating Officer)
Board seatGary Rieschel· per SEC Form D
Co-investorsF-Prime CapitalQiming Venture Partners USARaptor GroupWaterline VenturesExperian Ventures
Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).
HardwareHealthtechMedical DevicesMinneapolis, US
Martin Mayse(Founder)inSteve Dimmer(Founder)inDennis Wahr(President & CEO)inLisa Flaherty(Chief Strategy Officer)inSteve Sathre(Vice President of Finance)inSteve Paidosh(Vice President of Operations)
Board seatGary Rieschel· per SEC Form D
Co-investorsWindham Capital PartnersEndeavour VisionLightstone VenturesMorgenthalerRichard King Mellon FoundationSplit Rock Partners+2 more
Used car marketing service platform
画啦啦 (Hualala) offers online drawing and art classes for children, providing trial lessons that connect families with dedicated teachers.
ConsumerEdTechGuangzhou, CN
7k7k is a casual gaming portal that aggregates small games and browser-based games for a primarily young audience in China, founded in 2003.
ConsumerGamingMarketplacesMedia & EntertainmentChina, CN
Abogen is a biotechnology company developing mRNA-based therapeutics and vaccines, including an mRNA shingles vaccine and mRNA-encoded T-cell engagers for cancer such as B-cell non-Hodgkin lymphoma.
AI & Machine LearningBiotechDeep TechHealthtech
Bo Ying(Founder, Chairman and CEO)
Co-investors5Y CapitalCoatue ManagementFuzhou Jiebao Rongan Venture CapitalSoftBank Vision FundBoyu CapitalGL Ventures+7 more
A Chinese technology provider that develops OTA (over-the-air) firmware update and remote device management systems, including FOTA/DOTA solutions, differential upgrades, and a cloud-based OTA SaaS platform.
IoTMobility & TransportationSaaS
ACEA Therapeutics is a clinical-stage pharmaceutical company developing small molecule inhibitors, antibody drug conjugates, and cell therapies to address unmet needs in cancer, autoimmune disease, and COVID-19.
BiotechHealthtechMedical Devices
Oorstec (Guangdong Oorstec Micro-Nano Technology) develops a digital microfluidics platform based on proprietary active-pixel thin-film semiconductor arrays that generates and manipulates large numbers of microscale biological droplets in parallel.
BiotechDeep TechSemiconductorsFoshan, CN
Yang Su(Founder)in
Co-investorsLinear Capital
A Shanghai-based air purification technology company that designs and manufactures air filtration systems for both residential and industrial applications.
Advanced ManufacturingCleantechHardwareIoTShanghai, CN
Co-investorsGRC Sinogreen
AI Starfish is an AI company focused on intelligent diagnosis and treatment systems for cancer.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSocialHangzhou, CN
Akulaku is a payment and digital banking solutions platform serving 33 million customers, offering payment processing, digital banking services, and free shop setup with dedicated traffic support.
B2B MarketplacesFintech
Gordon Hu(Founder)William Li(Founder)
Co-investorsArbor VenturesCapria VenturesDCM VenturesEight Roads VenturesICU VenturesInnoVen Capital+4 more
Alamar Biosciences develops NULISA, an ultra-high-sensitivity, high-specificity technology for analyzing hundreds of protein biomarkers from small biofluid samples, building on the team's prior spatial genomics work (RNAscope).
BiotechDeep TechHealthtechFremont, US
Yuling Luo(Co-founder, CEO and Chair)inSteve Chen(Co-founder, COO and Director)inYiyuan Yin(Co-founder, VP of Technology)inTod White(President)inJustin McAnear(CFO)inXiao-Jun Ma(CTO)
Co-investorsIllumina VenturesSamsara BioCapital
Allorion Therapeutics is a drug development company focused on advancing new therapeutics.
BiotechHealthtech
Fang Li(Founder)in
Co-investorsINCE Capital
Amoy Diagnostics develops molecular diagnostic test kits for cancer detection, including PCR, IHC, FISH, and next-generation sequencing products that detect gene mutations such as PIK3CA, KRAS, NRAS, BRAF, and IDH1, as well as microsatellite instability.
BiotechDigital HealthHealthtechMedical DevicesXiamen, CN
Zheng Li-Mou(Founder)
Antengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates.
BiotechHealthtech
Jay Mei(Founder)
Co-investorsDecheng CapitalBoyu CapitalFountainVest Partners
Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer.
BiotechHealthtechFoster City, US
Peter Lin(Executive Officer)Guo-Liang Yu(Founder)Sanjeev Redkar(Founder)
BoardHung-Wen (Howard) Chen(Executive Officer, Director)Hung-Hsien Yen(Director)Yi-Kuei (Alex) Chen(Executive Officer, Director)
Co-investorsMaxpro VenturesPan-Lin CapitalSVE CapitalK2VC
APT Medical manufactures and supplies medical devices for electrophysiology and vascular interventions.
BiotechHardwareHealthtechMedical DevicesShenzhen, CN
APUS is a mobile internet company that develops a lightweight operating system and related products serving global users across emerging markets.
AI & Machine LearningCloud ComputingConsumerSaaS
Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsDecheng CapitalYuanBio Venture Capital
Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer.
BiotechFemTechMedical Devices
Kevin Pan(Founder)
Co-investorsEFung CapitalTriWise CapitalYF Capital
芯宿科技 (Atantares) develops molecular chips using semiconductor technologies such as integrated circuits, CMOS and MEMS to enable high-throughput, low-cost synthesis and detection of DNA, RNA and proteins.
BiotechDeep TechSemiconductorsSuzhou, CN
Xin Zhao(Founder)in
Co-investorsLair East Labs
Atom Semiconductor provides a thermocouple reference design that enables accurate temperature measurement with less than 1°C error, integrating anti-aliasing filters, bias circuits, and cold junction compensation.
HardwareIoTSemiconductorsHong Kong, HK
Co-investorsGobi Partners
Aureka Biotechnologies is a tech-bio startup that combines high-throughput digital biology data with generative AI to discover protein and antibody therapeutics.
AI & Machine LearningBiotechDeep Tech
Co-investorsDevice of Tomorrow Capital
BiotechNewton, US
Katharine Yen(Executive Officer, Director)Kate Yen(Founder)inChristopher Guiffre(Executive Officer)
BoardAlon Lazarus(Director)Anna French(Director)inAlexandra Cantley(Director)in
Co-investorsDCVC (Data Collective)Qiming Venture Partners USAApollo Health VenturesBrightEdgeDCVC BioPolaris Partners
AusperBio is a Phase II clinical-stage biopharmaceutical company developing oligonucleotide (ASO) therapeutics, with a focus on curative treatments for hepatitis B (HBV).
BiotechHealthtech
Guofeng Cheng(Founder)in
Co-investorsRA Capital
Axera Tech designs and manufactures AI inference system-on-chip (SoC) solutions for edge computing, endpoint devices, and autonomous vehicles.
AI & Machine LearningHardwareIoTSemiconductorsNot explicitly stated, CN
Co-investorsGGV CapitalGlory Ventures InvestmentsLegend Star
Baoyu Game develops and operates multiple mobile and web-based role-playing games themed around Chinese mythology, martial arts, and fantasy settings.
GamingGuangzhou, CN
BayOmics is a proteomics company founded in January 2022 that develops proprietary technologies and tools for protein research to advance disease diagnosis and drug discovery.
BiotechDeep TechMedical DevicesShenzhen, CN
A healthcare platform serving patients and medical institutions in China that integrates online consultation, pharmaceutical services, hospital management software, and insurance products.
Digital HealthHealthtechInsurTechBeijing, CN
Gao Yang(Founder)Hou Ying(Founder)Zhou Daixing(Founder)
Co-investorsLegend Capital
Chilam Chen(Founder)in
BioLink is a biotechnology company that develops and manufactures process equipment and consumables for life science applications, including recombinant protein drugs, vaccines, antibody drugs, cell therapy, and gene therapy production.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesShanghai, CN
Co-investorsApricot Capital
Biotree develops metabolomics and proteomics analysis platforms and services for research institutions and pharmaceutical companies, offering laboratory testing solutions, medical devices, and cloud-based lab information systems.
BiotechDeep TechDigital HealthHealthtechMedical DevicesShanghai, CN
邓军亮in
Bioyond develops intelligent laboratory automation platforms and robotic systems for experimental research environments, including vision systems and scheduling software.
AI & Machine LearningBiotechRoboticsShanghai, CN
Co-investorsPan-Lin Capital
Lingjie Xu(Founder)Michael Zhang Wen(Founder)Xu Lingjie(Founder)Zhang Wen(Founder)Zhang Wen Xu Lingjie(Founder)
Co-investorsCyberport Hong KongSky9 CapitalSource Code CapitalGaorong VenturesGlory Ventures InvestmentsHongShan Capital Group
BlockVision provides blockchain data infrastructure for EVM chains and Sui, including block explorer services, RPC nodes, indexing APIs, and validator services.
Crypto & Web3Data & InfrastructureDeveloper Tools
Co-investors6th Man VenturesCollab+Currency
Xiaocheng Wangin
Bondent manufactures a dental CBCT imaging system with multiple imaging modes (CBCT, panoramic, cephalometric, and periapical) designed for dental clinics.
Advanced ManufacturingAI & Machine LearningDigital HealthHardwareHealthtechMedical DevicesSaaSGuangzhou, CN
Co-investorsFuzhou Jiebao Rongan Venture Capital
Bouffalo Lab is a fabless IC design company that develops low-power wireless connectivity chips, including WiFi, WiFi 6, BLE, Zigbee, and combination AIoT chips supporting the Matter smart home standard.
HardwareIoTSemiconductorsNanjing, CN
Yonghua Song(Founder)
Boulder provides medication-assisted treatment for addiction through licensed specialists who prescribe buprenorphine, supported by dedicated care teams offering medical care, peer recovery coaching, and care coordination accessible via a digital platform.
Digital HealthHealthtechMental HealthBoulder, US
Stephanie Papes(Cofounder)Stephanie Strong(Founder)Jordan Nof(Director)Frank Ingari(Director)Josh Kopelman(Director)
Co-investorsAdvance Venture PartnersAlumni VenturesFirst Round CapitalGaingelsGreycroftLaerdal Million Lives Fund+5 more
__Twitter.png)
ByteDance builds a portfolio of digital platforms and services focused on short-form video, content creation, e-commerce, and workplace collaboration, serving creators and consumers globally.
Creator EconomyE-commerceMedia & EntertainmentBeijing, CN
Yiming Zhang(Founder)inRubo Liang(Founder)inZhang Yiming(Founder)Liang Rubo(Founder)
Co-investors1435 Capital3Comma Capital5Y CapitalAccess Ventures (New York)Aglae VenturesAlanda Capital Holding Limited+35 more
Co-investorsVertex Ventures China
Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Co-investorsQiming Venture Partners USASlater Technology FundAccess IndustriesAtlas VentureClal Biotechnology IndustriesCowen Healthcare Investments+1 more
Caidya provides clinical trial management solutions designed for pharmaceutical and biotech companies seeking to improve trial efficiency and patient outcomes through integrated, patient-centric approaches.
BiotechDigital HealthHealthtech
Barbara Lopez Kunz(Chief Executive Officer)inMichael Clay(Chief Operating Officer)inSharon Moore(Chief Medical Officer)inBrandon Pallott(Chief Commercial Officer)inMiron Lila(Chief Corporate Development Officer)inJohn Scott(Chief Information Officer)in
Co-investorsVivo CapitalHatteras Venture Partners
Develops specialty products for orphan diseases and targeted cancers.
James Xue(Founder)
Co-investorsGeneral AtlanticRA Capital
CandidRx develops T-cell engager antibodies to treat autoimmune diseases by redirecting T-cells to eliminate autoreactive B-cells.
BiotechHealthtechSan Diego, US
Ken Song(Chairman, President and CEO)inKenneth Song, M.D.(Executive Officer, Director)Arvind Kush(Executive Officer)Timothy Lu, M.D.(Executive Officer)inBernie Huyghe, Ph.D.(Executive Officer)
BoardJeffrey Tong, Ph.D.(Director)
Co-investorsForesite CapitalLifeSci Venture PartnersOrbiMedSamsara BioCapitalTCG CrossoverThird Rock Ventures+2 more
CanSino Biologics develops and manufactures vaccines, including tetanus, whooping cough, pneumococcal, meningococcal, and COVID-19 vaccines for prevention of infectious diseases.
BiotechHealthtechMedical DevicesTianjin, CN
Helen Mao Huihua(Founder)Qiu Dongxu(Founder)Yu Xuefeng(Founder)Zhu Tao(Founder)
Co-investorsFortune Venture Capital
Yuchen Yang(Founder)in
Ju Park(Founder)in
Chaitin provides enterprise cybersecurity solutions including vulnerability management, cloud workload protection, web application firewalls, and AI-powered threat detection for multiple industries.
AI & Machine LearningCybersecurityEnterprise SoftwareBeijing, CN
Clounix designs and develops advanced network and communication chips and software solutions for telecommunications and digital transformation customers, enabling secure next-generation intelligent network infrastructure.
Cloud ComputingDeep TechHardwareSemiconductorsShanghai, CN
Co-investorsChina Internet Investment FundOceanpine CapitalOndine Capital
Complete Omics develops a clinical proteomics platform that identifies patient-specific neoantigens to enable personalized cancer therapeutics.
AI & Machine LearningBiotechDigital HealthMedical Devices
Ming Zhang(Co-Founder and Chief Intellectual Property Officer)
Connect Biopharm develops next-generation therapeutics for inflammatory diseases.
Biotech
Pan Wubin(Founder)Zheng Wei(Founder)
Co-investorsLAVLilly Asia Ventures
ContentBox operates a blockchain-based infrastructure for the digital content industry, providing a unified payout system, shared content and user pools, and blockchain identity/attribution services across applications.
ConsumerCrypto & Web3Media & Entertainment
Co-investorsNirvana CapitalSora Ventures
Convenient Power designs and licenses integrated circuits for wireless charging and automotive power management applications used by major mobile and automotive manufacturers.
EnergyHardwareIoTSemiconductorsChengdu, CN
A Chinese enterprise training and talent development platform that integrates learning with instant messaging and AI technology.
AI & Machine LearningEdTechEnterprise SoftwareHR TechSaaS
Co-investorsPuhua CapitalYunqi Partners
Crema.co offers a coffee subscription service that delivers specialty beans from independently owned, award-winning roasters to consumers at home and to workplaces.
ConsumerDirect to ConsumerE-commerce
Emily McIntyreTyler TateGeorge Brooks(Founder)inDan Linhart(Founder)in
Co-investors500 Global
Crown Bioscience is a contract research organization based in California providing discovery, preclinical, and translational platforms and services for oncology and immuno-oncology drug development.
BiotechHealthtechMedical DevicesCalifornia, US
Co-investorsAcorn Pacific VenturesGRC SinogreenLAVLilly Asia VenturesTrans-Pacific Technology Fund
Cornerstone Robotics (康诺思腾), founded in 2019, develops, manufactures, and sells high-end surgical robots for medical centers and healthcare providers.
HealthtechMedical DevicesRobotics
Samuel Au(Founder)inAlexis Cheng(Founder)Zerui Wang(Founder)
Co-investorsAlpha JWC VenturesGaorong VenturesK2VC
Cure Genetics develops two biotechnology platforms: AIMS CAR-NKT, a cell therapy targeting solid tumors such as clear cell renal carcinoma, and the VELP directed-evolution library platform for gene therapy applications addressing the nervous system, heart, and kidneys.
BiotechHealthtech
Co-investorsBlue Ocean Capital Group
Dangles is a gaming content platform covering PC games, mobile games, and related news, reviews, and resources for players.
GamingMarketplacesMedia & EntertainmentBeijing, CN
Co-investorsPrysm Capital
DeepWay (深向) develops new-energy heavy-duty trucks and autonomous driving technology aimed at building unmanned freight robots (RoboTrucks) for logistics fleets.
AI & Machine LearningLogistics & Supply ChainMobility & TransportationBeijing, CN
Wan Jun(Founder)
Dezhen Technology provides information technology solutions and IT strategy consulting for hospitals and medical institutions, covering clinical care, research, and management.
Digital HealthHealthtechSaaS
Dingdong Maicai is an online grocery retailer offering fresh food and groceries ordered via a mobile app, with fast delivery (as quick as 29 minutes) and no minimum order threshold.
ConsumerE-commerceFoodTechMiami Beach, US
Kim Perell(Manager)James Brennan(Manager)Liang Changlin(Founder)
Co-investorsCoatue ManagementGeneral AtlanticSoftBank Vision FundDST GlobalFortune Venture CapitalGaorong Ventures+2 more
Caidya is a global full-service clinical research organization (CRO) that supports biopharmaceutical companies with clinical trial design, execution, and patient recruitment across more than 40 countries.
BiotechDigital HealthHealthtech
Co-investorsQuan Capital
Docin is a document sharing and collaboration platform where users can upload, share, and browse documents online.
ConsumerEdTechMarketplacesMedia & EntertainmentSaaSBeijing, CN
yujie qi(Founder)in
DP Technology develops AI for Science tools and intelligent systems for scientific discovery, including its Uni-Fold/宇知 science discovery engine, computation and simulation software (Hermite, Piloteye), and the Bohrium research platform.
AI & Machine LearningBiotechDeep TechBeijing, CN
Linfeng Zhang(Founder)inSun Weijie(Founder)Zhang Linfeng(Founder)
Co-investorsSource Code CapitalVision Plus Capital
Clear Orthod (可丽尔博士) makes near-invisible clear aligners for orthodontic treatment, with product lines for both adults (C4 digital clear correction) and children (C3 full-cycle version).
HardwareHealthtechMedical DevicesShanghai, CN
Element Science is a medical technology company that develops the Jewel, an FDA-approved adhesive-based wearable cardioverter defibrillator designed to protect patients at risk of sudden cardiac arrest.
AI & Machine LearningDigital HealthHardwareHealthtechMedical DevicesSan Francisco, US
Uday N. Kumar(Executive Officer, Director)inUday Kumar(Founder)in
BoardRussell Hirsch(Director)Neil Exter(Director)inKrishna Yeshwant(Director)inWilliam H. Kucheman(Director)
Co-investorsGV (Google Ventures)Third Rock VenturesDeerfield Management Company
Zhichang Group develops industrial control systems, robots, machine-vision software, and industrial AI models for manufacturing sectors including steel, construction machinery, shipbuilding, woodworking, and liquor production.
Advanced ManufacturingAI & Machine LearningRobotics
甘中学(Founder)
Empirico is a San Diego-based clinical-stage biotech that uses human genetics data and computational methods to discover disease targets and develop siRNA and antibody therapeutics.
BiotechSan Diego, US
Omri Gottesman(Executive Officer, Director)inShannon Bruse(Executive Officer, Director)inBrian Cajes(Executive Officer)in
BoardJohn Hamer(Director)Kolluri Swaroop(Director)
Co-investorsDCVC (Data Collective)Felicis VenturesQiming Venture Partners USADCVC Bio
Entact is a drug discovery company developing treatments for patients.
BiotechDeep TechWatertown, US
Victoria Richon(Executive Officer, Director, Promoter)inRuben Tommasi(Chief Scientific Officer)Michael Gutch(Chief Operating Officer)Alon Lazarus(Director)
BoardAndrew Sinclair(Director)Anna French(Director)in
Co-investorsvenBio PartnersAbingworthArkin CapitalvenBio Global Strategic
Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Chloe You(Chief Medical Officer)inKelly Shi(Chief Financial Officer)
Co-investorsOrbiMedTrinity Innovation Bioventure Singapore
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
1Yongcloud616DX (Yaodian 100)7KM9DiamondAbcfintechAbdera TherapeuticsAcea BioscienceAdvanced IC substrates ThinktransAeonmed Co. LtdAfujingyouAgloe Medical TechnologiesAi PrimeAilomics TherapeuticsAiqiyi (爱奇艺)AlltechAlphabiopharmaAmoy DiagnosticsAnssure PharmaAnxin DoctorAnxinyishengAohua EndoscopyApex PartnersAplumARMO BioSciencesBang-Er OrthopaedicBaoji GameBbi LifesciencesBelief BiomedBesunyen/HighstarBilibili (B站)Bion Interactive Entertainment Company LimitedBioscienceBird HealthBjgoodwillBlack UniqueBlue Satellite Communication Technology Co., LTDBrise PharmaceuticalsBroncusB站CaimiCaptive8CASI Pharmaceuticals (再鼎医药)CastboxCdhotCdthchemCehomeCencorp AutomationCentreChangeducationChaodian CultureChatailChemlexChina Auto CareChina FifChina Richen.ComChinabscChinacacheChuhangChumanChushouCitic PharmaClinflashCmlabsColandCoohuaCoremedCornerstone RoboticsCorp.B2BCsr BiotechCubenergyCuttCygiaDajiabaoDearer MedicalDelta MedicalDesanoDianping (大众点评)DingdongDingxiang (丁香)Dining SecretaryDinovamedtechDL BiotechDongsheng FusionDstzcEigenEigencommElevation OncologyEndonom
Browse all 527 investments with full details →
▶327 more tracked companies
ET HealthcareEvermoreFangtekFanliFimiFinernFirstgridForgameFrontagelabFrontisFuze Health (fka LetsGetChecked)GalbotGammastarGanleeGaston Acuña (高端机器人)GaugeneGeneditbioGenki ForestGenorbioGlightmedGohooGuangjing EnergyGyennoHanqigroupHaoyikuHashquarkHealthgenetechHeidianerHesai TechnologyHillevaxHippo Graph (星环科技)HonessHortorgamesHoumoHugemedHuimeiHxgroupHyperealHyperzIceonlineIcosavaxIdsmanagerIgetgetIlovewoofImileImmune PathInbilinInfervisionInfinigence AIInflyInfStonesInnosticInscinstechInsight LifetechInsta360InventisbioInxxIqi IncIron ArmourItianguaIvderJacobiopharmaJcxjJfkbioJhtcmJiayuanJinkongautoJoesfuturefoodJsgaiyaJurenJustmedicalKaiheikejiKaixin001KeChow PharmaKeysinoKezar Life SciencesKingswareKintepKktv5KoalareadingKuwoLagouLanzaTechLeapstackLetelLiangyihuiLiangzizhigeLieshengLih InvestLongbioLongwillLpaminaLtztherapeuticsLuotianyiLupuamcMafengwoMantaManta NetworkMarvel TechMatrixportMatwingsMech MindMedicaldlMedmotionMedsciMedxtmcMeetfutureMeitu (美图)Meituan DianpingMicrotechmdMitralignMiwuyyMk SemiMOBIKEMogujieMoodytigerMoreticketsMorewisMuchoMufan PowerMumble AIMusical.lyMuttoincNasn AutoNovamabNovastNovoproteinNurienNurotronNvxcloudsOcegOne ChipOneapmOneaspOrigeneOriginal PointPelliotPetkitPhotoncrystalPluslifePPS影音PratilipiPrimelifesciencePrismlabPrmeasureQiangsenmedicalQiming USQingflowQiniuQuickpicRdbioReddoorzReetianRenasant BioRensenergyRhino Federated ComputingRhino HealthRiboX TherapeuticsRMBRoborockRoundhealth (圆心科技)Rox MotorRuhnnSanegene BioSano DynamicsSany Hydrogen EnergySanyou MedicalSanyoumedSceneraySchrödingerSequoiadbSgeetSh Eco.ComShanzhenSharpaSharpaShenogenShenzhou Cell (神州细胞)ShineheShiyunjiShsongliShulanhealthSiereduSinobiologicalSinomdtSinotauSinovision TechSnarkifySnowball (Xueqiu)SnssurgicalSONOSILICONSpeschinaStairway MedicalStepfunStructure TherapeuticsSuhSunnydentalSunyurSupermagSwapSweetomeSynapsorTT4GameTandemaiTasogareTellgenTenpoint TherapeuticsTheraheartThoroughThorough FutureTianhu TechnologyTigerGraphTigermedTingsnTisencTokenTongshield (同盾科技)TongzhuogameTOPI Imaging TechnologyTourmaline BioTpmedicalTransparentics (透景)Tripod GlpTrytrytwTuhu CarTujia (途家网)TungeeTutorabcUBTechUmoja Biopharma, Inc.Unisound (云知声)VanclVeerVenus MedtechVignette BioVinnoVINNO TechnologyVistelVlightvVongihealthVrmedicalWacaiWanwu PoyuanWebcomicsappWecare BioWeDoctorWeDoctor GroupWifigxWindwardWindward BioWowjoyWoxiaoyaWx VisionproXbonlineXellsmartXiaoe TechXiaohongshu (小红书)XiaomiXiaomishuXiaoniaokuaiyanXiaoyiXiudanXskyXy51YanyinYesmroYlhyoilYoaaYpxfoodYuanbaobaoxianYuanXin Tech (MiaoShou Doctor)Yuanxin TechnologyYunjichinaYunqiYYGZaiZchb WaterZd MedZeen HealthZegoZhaohu365ZhaosuliaoZhixiaolezinc-fiveZjbangerZuoshouyishengZuzuche云知声优必选再鼎再鼎医药同盾科技同盾科技 (Tongdun Technology)哔哩哔哩哔哩哔哩 (Bilibili)圆心科技大众点评妙手医生小米康希诺生物微医微医集团摩拜单车 (Mobike)数坤科技文远知行星环星环 (Transwarp)星环科技智谱华章 (Zhipu AI)泰格医药海博思创海博思创 (Hyperstrong)生数科技知乎石头科技神州细胞神州细胞 (Sinocelltech)美图触宝科技 (CooTek)贝瑞基因透景透景 (Genecast/Toujing)透景生命途家网镁睿化学马蜂窝
Exits · 9
7 IPOs · 2 acquisitions · showing 8Korro BioNASDAQ: KRROSchrodingerNASDAQ: SDGRTuyaNYSE: TUYAWeiboNASDAQ: WBWeRide (文远知行)NASDAQ: WRDZai LabNASDAQ: ZLABZhihu (知乎)NYSE: ZHCadenttxacq. by Novartis
Portfolio news
latest coverage across their companies
Sharpa · kr-asia.com · Sep 5, 2026
Tenpoint Therapeutics · ophthalmologytimes.com · Aug 30, 2026
Caidya · pharmasource.global · Jul 1, 2026
Leyden Labs · techfundingnews.com · Jun 25, 2026
Akulaku · trysignalbase.com · Jun 9, 2026
Bytedance · research.contrary.com · Jun 8, 2026
Windward Bio · finsmes.com · May 5, 2026
Frequently asked questions
- How many investments has Qiming Venture Partners made?
- Qiming Venture Partners has 527 tracked investments, 9 of which have exited, including 15 dated in the last 24 months.
- What stage does Qiming Venture Partners invest at?
- Qiming Venture Partners invests at the Seed, Series A, Series B stages.
- What sectors does Qiming Venture Partners focus on?
- Qiming Venture Partners focuses on AI & Machine Learning, Biotech, Cleantech, Consumer, Data & Infrastructure, Digital Health, E-commerce, Energy, Enterprise Software, Fintech, Gaming, Hardware, Healthtech, Medical Devices, Mobility & Transportation, Robotics, SaaS, Sector Agnostic, Semiconductors, Social.
- Where is Qiming Venture Partners located?
- Qiming Venture Partners is headquartered in Beijing, CN.
- Does Qiming Venture Partners lead rounds?
- Qiming Venture Partners typically participates in rounds rather than leading them.
- Who does Qiming Venture Partners co-invest with?
- Qiming Venture Partners most often shares deals with HongShan Capital Group, LAV, Lilly Asia Ventures, among 161 tracked co-investors.
- What size deals does Qiming Venture Partners back?
- Across 11 deals with disclosed amounts, Qiming Venture Partners has joined rounds of $3M – $120M (median $37M).
Media · Podcasts & interviews
featuring the teamQiming Venture Partners' JP Gan endorses Vivi 启明创投甘剑平为Vivi背书
Vivi in the Valley · JP Gan
Welcome Gary Rieschel, Founding Managing Partner of Qiming Venture Partners, as the new Chair of Asia Society Northern California Advisory Board. “Gary... | By Asia Society Northern California
Gary Rieschel · facebook.com
Gary Rieschel of Qiming Venture Partners on Big Sky Virtual Town Hall | Gary Rieschel is the Founding Managing Partner of Qiming Venture Partners. EBS spoke with Rieschel about the economic impacts created by the pandemic,... | By Explore Big Sky
Gary Rieschel · facebook.com
Co-investors · 19
INCE Capital is a global venture capital firm that invests in early to expansion-stage companies innovating in AI, technology, consumer, and biotech.
Source Code Capital is a Chinese venture capital firm whose team comes from investment management, product/technology, consulting, and media backgrounds.
Granite Asia is a private capital and multi-asset investment platform in Asia that partners with founders to build industry champions, and runs the Granite Asia Fellows Programme for founders building global companies from Asia.
Vivo Capital is a global healthcare-focused investment firm operating a multi-strategy platform spanning venture capital, private equity, and public equity. It aims to expand healthcare access and drive innovation through its 'Ecosystem Strategy.'
Shunwei Capital is a venture capital firm focused on backing founders in high-tech industries, aiming to help entrepreneurs build world-leading enterprises with capital and operational experience.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
5Y Capital positions itself as entrepreneurs who happen to run a venture firm, focusing on finding founders with "crazy" visions that contradict market consensus when others dismiss them as unrealistic. The firm has built a track record of early bets on Chinese tech leaders like Kuaishou, Xiaomi, and SenseTime, while deliberately expanding into new domains like AI infrastructure and biotech despite having no prior experience in those sectors.
This page announces that GGV Capital split into two separate firms in March 2024: Granite Asia (Singapore, covering APAC) and Notable Capital (US, based in Silicon Valley with offices in San Francisco and New York, investing in the US, Israel, Europe, and Latin America).
Dragonfly is a crypto-focused investment firm comprising Dragonfly Ventures, Dragonfly Liquid, and Metastable, an early crypto hedge fund it acquired. It invests in and researches blockchain, tokens, and crypto companies.
RTW Investments L.P. is a New York-based venture capital firm investing across the biopharmaceutical and medical technology sectors from early stage through later rounds. The firm partners with companies and academic institutions developing new therapeutic approaches and medical devices.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
▶7 more co-investors
Alpha JWC VenturesLuminous VenturesMPM BioImpactProsperity7 VenturesIllumina VenturesAsset Management VenturesDigitalis Ventures
Firms observed investing alongside Qiming Venture Partners, from public investor directories. Shared companies are the overlap with Qiming Venture Partners's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
SBI Investment Korea is a Korean asset management firm within the SBI Group that operates venture capital and private equity funds, positioning itself as a 'New Industry Creator'.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.